Breathing gas could save lives in critical lung failure
NCT ID NCT07334873
Summary
This study is testing whether adding inhaled nitric oxide gas to standard treatment can help adults with severe Acute Respiratory Distress Syndrome (ARDS) survive and spend less time on breathing machines. Researchers will compare 536 patients who receive either the nitric oxide treatment or a placebo, along with standard care, to see if it reduces deaths within 28 days. The goal is to find a better way to control this life-threatening lung condition that often requires intensive care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS (MODERATE OR SEVERE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.